Patients living with asthma depend on access to inhaled respiratory medicines. As an asthma patient and the mother of three of my children who live with the disease, I know firsthand how important consistent access to diverse treatment options is for staying healthy.
However, high costs at the pharmacy counter force patients and parents like me to make some hard choices. We must do better. This is why Congress and the administration must reform one of the true drivers of high health costs – pharmacy benefit managers (PBMs).